Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Alx Oncology Holdings (ALXO) Leases (2021 - 2023)

Alx Oncology Holdings' Leases history spans 3 years, with the latest figure at $1.1 million for Q3 2023.

  • For Q3 2023, Leases fell 80.54% year-over-year to $1.1 million; the TTM value through Sep 2023 reached $1.1 million, down 80.54%, while the annual FY2022 figure was $5.6 million, 703.71% up from the prior year.
  • Leases for Q3 2023 was $1.1 million at Alx Oncology Holdings, down from $5.2 million in the prior quarter.
  • Across five years, Leases topped out at $6.1 million in Q2 2022 and bottomed at $600000.0 in Q1 2022.
  • The 3-year median for Leases is $5.2 million (2023), against an average of $3.6 million.
  • The largest YoY upside for Leases was 800.0% in 2023 against a maximum downside of 80.54% in 2023.
  • A 3-year view of Leases shows it stood at $700000.0 in 2021, then surged by 703.71% to $5.6 million in 2022, then tumbled by 79.61% to $1.1 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Leases are $1.1 million (Q3 2023), $5.2 million (Q2 2023), and $5.4 million (Q1 2023).